课题基金 / 基金详情

Mechanisms of beta-cell failure in diabetes

Mechanisms of beta-cell failure in diabetes
糖尿病β细胞衰竭的机制
批准号:
nhmrc : 427616
负责人:
A/Pr David Laybutt
金额:
$35.81万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2007
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2007-01-01 至 2009-12-31

项目摘要

项目成果

A/Pr David Laybutt的其他基金

相似基金

相关文献

中文摘要
翻译
目前2型糖尿病的流行是一个主要的全球健康问题,超过7%的澳大利亚人患有这种疾病。虽然肥胖和胰岛素抵抗之间存在明确的关系,但大多数超重个体不会患2型糖尿病,因为他们的胰腺β细胞通过增强胰岛素分泌进行补偿。β细胞代偿的失败是糖尿病发展的根本。β-细胞是一种高度特化的细胞,具有独特的代谢特征和分化,特别适合使这些细胞能够感知循环葡萄糖水平的波动并相应地分泌胰岛素。我们提出,在易感个体中,由于肥胖和胰岛素抵抗的增加而导致血糖(高血糖症)和脂质水平的逐渐升高,导致适当胰岛素分泌所必需的基因的独特表达模式的丧失。这加剧了高脂血症,其导致进一步的β细胞去分化并最终通过细胞凋亡导致β细胞死亡。我们最近在几种糖尿病模型中发现了支持这一假设的证据。我们建议使用动物研究和细胞培养系统来研究以下对我们理解β细胞衰竭和进展为糖尿病很重要的假设:1)β细胞表型的丧失(去分化)是衰竭β细胞中胰岛素分泌功能丧失的基础。2)高脂血症在调节β细胞去分化的进程中起着关键作用。3)关键候选基因产物的过表达在将高脂血症与β细胞分泌丧失联系起来中起着不可或缺的作用。4)内质网应激是糖尿病中β细胞死亡所必需的。我们的研究将为我们理解为什么β细胞在糖尿病中失败做出重大贡献,并旨在为糖尿病的治疗提供新的治疗靶点。
英文摘要
The current epidemic of type 2 diabetes represents a major global health problem, with over 7% of the Australians suffering the disease. While there is a well-established relationship between obesity and insulin resistance, the majority of overweight individuals do not develop type 2 diabetes because their pancreatic beta-cells compensate with enhanced insulin secretion. It is the failure of beta-cell compensation that is fundamental to the development of diabetes. The beta-cell is a highly specialised cell with a unique metabolic profile and differentiation specifically geared towards making these cells able to sense fluctuations in circulating glucose levels and secrete insulin accordingly. We propose that in susceptible individuals, a gradual rise in blood glucose (hyperglycaemia) and lipid levels resulting from increasing obesity and insulin resistance leads to a loss of the unique expression pattern of genes necessary for appropriate insulin secretion. This exacerbates hyperglycaemia, which causes further beta-cell dedifferentiation and eventually the death of beta-cells by apoptosis. We have recently found evidence in several models of diabetes that supports this hypothesis. We propose to use animal studies and cell culture systems to investigate the following hypotheses important for our understanding of beta-cell failure and progression to diabetes: 1) The loss of beta-cell phenotype (dedifferentiation) underlies the loss of insulin secretory function in failing beta-cells. 2) Hyperglycaemia plays a critical role regulating the progression to beta-cell dedifferentiation. 3) The overexpression of key candidate gene products play an integral role linking hyperglycaemia to the loss of beta-cell secretion. 4) Endoplasmic reticulum stress is necessary for beta-cell death in diabetes. Our studies will make a major contribution to our understanding of why beta-cells fail in diabetes and aim to provide novel therapeutic targets in the treatment of diabetes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
New molecular mechanisms of islet protection against diabetes
  • 批准号:
    nhmrc : 1144206
  • 项目类别:
    Project Grants
  • 资助金额:
    $45.52万
  • 财政年份:
    2018
  • 负责人:
    A/Pr David Laybutt
  • 依托单位:
New molecular mechanisms of islet protection against diabetes
  • 批准号:
    nhmrc : GNT1144206
  • 项目类别:
    Project Grants
  • 资助金额:
    $67.33万
  • 财政年份:
    2018
  • 负责人:
    A/Pr David Laybutt
  • 依托单位:
Control of insulin secretion by Y1 receptor signalling
  • 批准号:
    nhmrc : 1144286
  • 项目类别:
    Project Grants
  • 资助金额:
    $45.68万
  • 财政年份:
    2018
  • 负责人:
    A/Pr David Laybutt
  • 依托单位:
Control of insulin secretion by Y1 receptor signalling
  • 批准号:
    nhmrc : GNT1144286
  • 项目类别:
    Project Grants
  • 资助金额:
    $67.56万
  • 财政年份:
    2018
  • 负责人:
    A/Pr David Laybutt
  • 依托单位:
国内基金
海外基金
人附睾蛋白4靶向调控TGF beta-smad轴加剧克罗恩病相关肠纤维化进程的作用机制研究
AP2B通过WNT/BETA-CATENIN调控颅骨元件成骨活性差异的 分子机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    孙贤杰
  • 依托单位:
TGF-beta通路通过降低自噬-基因组稳定性介导胶质母细胞瘤间质亚型替莫唑胺耐药的机制研究
  • 批准号:
    82303919
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    陈鹭跃
  • 依托单位: